Bure’s original investment in Mölnlycke Health Care was made in 1998 together with Nordic Capital and other institutional investors. Since then, Bure has made follow-on investments in 2001 in connection with Mölnlycke’s acquisition of Barrier Brand. Bure’s holding prior to the sale is approximately 7.5 per cent. “The sale of Mölnlycke will enable us to meet our most important goal – a debt-free Bure. We have now begun a new chapter in which our increased freedom of action will also provide scope for new business opportunities,” says Mikael Nachemson, President of Bure. The sale is condition on the approval of the Swedish Competition Authority, which is preliminarily awaited in mid-June 2005. Gothenburg, 21 April 2005 Bure Equity AB (publ) For additional information contact: Mikael Nachemson, President +46 (0)31-708 64 20 Johanna Pettersson, IR/Corporate Communications +46 (0)31-708 64 49
//bure.se/wp-content/uploads/sites/23/2015/05/Bure_240.jpg 0 0 Martin Ekström //bure.se/wp-content/uploads/sites/23/2015/05/Bure_240.jpg Martin Ekström2005-04-21 11:26:212005-04-21 11:26:21Bure to divest holding in Mölnlycke Health Care – exit gain of approx. SEK 330 million
Bure has signed an agreement for the sale of its entire holding in Mölnlycke Health Care to Apax Partners. The sale will provide Bure with proceeds in the range of SEK 500 million and an estimated exit gain of around SEK 330 million.